Non Iodine Avid Bone Metastasis from Differentiated Thyroid Cancer: A Case SeriesCorrespondence Address :
Dr. Sudheesh Manoharan,
Senior Resident, Department of Surgical Oncology, Malabar Cancer Centre, Kannur-670103, Kerala, India.
Differentiated Thyroid Carcinoma (DTC) constitute up to 90 per cent of all thyroid malignancy. The overall prognosis of patients with DTC is good, but when bone metastases are present, the overall survival at 10 years ranges from 13 to 21%. Treatment of metastatic thyroid cancer that are non iodine avid offers a surgical challenge. This paper reviews a series of three cases of DTCs with bone metastasis treated by surgery.
Follicullar carcinoma, Papillary carcinoma, Radioiodine ablation
Sudheesh Manoharan, Sajith Babu Thavarool, Sivakumar Thiagarajan,Satheesan Balasubramanian, Atul Singh. NON IODINE AVID BONE METASTASIS FROM DIFFERENTIATED THYROID CANCER: A CASE SERIES. Journal of Clinical and Diagnostic Research [serial online] 2017 October [cited: 2018 Jan 18 ]; 11:XR01-XR03. Available from
Date of Submission: Feb 05, 2017
Date of Peer Review: Mar 18, 2017
Date of Acceptance: Jul 27, 2017
Date of Publishing: Oct 01, 2017
FINANCIAL OR OTHER COMPETING INTERESTS: None.
- Emerging Sources Citation Index (Web of Science, thomsonreuters)
- Index Copernicus ICV 2016: 132.37
- Academic Search Complete Database
- Directory of Open Access Journals (DOAJ)
- Embase & EMbiology
- Google Scholar
- HINARI Access to Research in Health Programme
- Indian Science Abstracts (ISA)
- Journal seek Database
- Popline (reproductive health literature)